Codiak BioSciences Launches With $80M Financing

Codiak Biosciences launches with $80m financing to develop exosome-based products.

Codiak Biosciences is developing exosomes, natural vesicles that mediate inter-cellular communication, as both a powerful therapeutic modality and an advanced diagnostic system. Codiak is building a world-class team and has generated and acquired foundational intellectual property that will allow it to capitalize on the unique potential of exosome biology.

Share this post